These effects, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the concept of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Ailments. Moreover, the conolidine molecule did https://juliana381efc4.blogadvize.com/profile